Skip to main content

#Influenza and Other Respiratory Viruses Research #References (by AMEDEO, Dec. 21 '25)

Image
By G.M.

 


    Antimicrob Agents Chemother

  1. LEONARD VHJ, Vidales DB, Taft BR, Hesse MJ, et al
    Identification and characterization of a novel inhibitor of influenza A virus that acts by blocking nucleoprotein oligomerization.
    Antimicrob Agents Chemother. 2025 Dec 19:e0114925. doi: 10.1128/aac.01149.
    PubMed         Abstract available


    Arch Virol

  2. BEDAIR NM, Sakr MA, Mourad A, Eissa N, et al
    Genetic characterization of highly pathogenic avian influenza A/H5N8 virus isolated from commercial poultry farms in Egypt reveals zoonotic potential.
    Arch Virol. 2025;171:29.
    PubMed         Abstract available


    Biochemistry

  3. WESTMAN H, Hammarstrom P, Nystrom S
    SARS-CoV-2 Spike Protein Amyloid Fibrils Impair Fibrin Formation and Fibrinolysis.
    Biochemistry. 2025;64:4818-4829.
    PubMed         Abstract available


    Epidemiol Infect

  4. STADHOUDERS L, Hoogteijling EM, Duijts L, Lebon A, et al
    Trends in asthma exacerbations in children before, during, and after the COVID-19 pandemic.
    Epidemiol Infect. 2025;153:e138.
    PubMed         Abstract available


    J Clin Microbiol

  5. BATAC ALR, Marks M, Tucker JD, Peeling RW, et al
    Syphilis self-testing and implications for syphilis control and prevention.
    J Clin Microbiol. 2025 Oct 21:e0098225. doi: 10.1128/jcm.00982.
    PubMed         Abstract available


    J Gen Virol

  6. EASTON V, McPhillie MJ, Santos IA, Hall P, et al
    Identification and characterization of candidate inhibitors of the SARS-CoV-2 nsp14 3'-5' exoribonuclease.
    J Gen Virol. 2025;106.
    PubMed         Abstract available


    J Infect Dis

  7. ZHU MQ, Kuan G, Maier HE, Lopez R, et al
    Stunting Increases Influenza Virus Shedding Duration in Preschool/School-Aged Children.
    J Infect Dis. 2025 Dec 18:jiaf641. doi: 10.1093.
    PubMed         Abstract available

  8. ROUPHAEL N, Tanios R, Traenkner J, Pauly MD, et al
    Feasibility and Safety of Aerosolized Influenza Virus Challenge in Humans Using Two Modern Delivery Systems.
    J Infect Dis. 2025 Dec 16:jiaf603. doi: 10.1093.
    PubMed         Abstract available


    JAMA

  9. ZAMBON M, Hayden FG
    Influenza A(H3N2) Subclade K Virus: Threat and Response.
    JAMA. 2025 Dec 18. doi: 10.1001/jama.2025.25903.
    PubMed        

  10. SCHWEITZER K
    A New H3N2 Influenza Strain Is Raising Concerns About This Flu Season.
    JAMA. 2025 Dec 19. doi: 10.1001/jama.2025.25205.
    PubMed        


    PLoS One

  11. OH YJ, Rasul ME, Lim JI, Calabrese C, et al
    Targeting anger for COVID-19 prevention: The motivating role of anger on media use and vaccination intention.
    PLoS One. 2025;20:e0338183.
    PubMed         Abstract available

  12. MUIR T, Poudyal CS, De Lima R, Otaki F, et al
    Investigating organizational resilience in a medicine and health sciences university in United Arab Emirates.
    PLoS One. 2025;20:e0338728.
    PubMed         Abstract available

  13. CORTESI M, Pendenza F, Haddon E, Schiavio A, et al
    Can creative activities and mind-body practices help enhance well-being and mental health awareness? An exploratory qualitative study in UK higher education.
    PLoS One. 2025;20:e0338938.
    PubMed         Abstract available

  14. TINNERHOLM LJUNGBERG H, Wallberg M, Aboagye E, Bergstrom G, et al
    'Wish you were here': Managers' experiences of hybrid work in higher education.
    PLoS One. 2025;20:e0339120.
    PubMed         Abstract available

  15. BERCEANU C, Bertolotti F, Arshad N, Patrascu M, et al
    Understanding the mechanisms of infodemics: Equation-based vs. agent-based models.
    PLoS One. 2025;20:e0338614.
    PubMed         Abstract available

  16. ARAUJO JIF, Batista FAM, De Souto Medeiros MR, Sena BO, et al
    The use of social media as an influence on vaccination rates: A systematic review protocol.
    PLoS One. 2025;20:e0334114.
    PubMed         Abstract available

  17. FAN J, Yang Y, Zhang F, Wu X, et al
    Analysis of molecular mechanism of Chinese medicine Jinhong decoction (JHD) in synergistically treating sepsis and COVID-19 based on network pharmacology.
    PLoS One. 2025;20:e0339457.
    PubMed         Abstract available

  18. PARK J, Shon C
    The impact of COVID-19 on walking practices in Korea: Policy implications for Urban health and physical activity resilience.
    PLoS One. 2025;20:e0338875.
    PubMed         Abstract available

  19. BRUNEKREEF J, Teslya A, Buskens V, Nunner H, et al
    Impact of adherence and stringency on the effectiveness of lockdown measures: A modelling study.
    PLoS One. 2025;20:e0338818.
    PubMed         Abstract available

  20. GYAWALI N, Caragea D, Caragea C, Mohammad SM, et al
    The shifting landscape of vaccine discourse: Insights from a decade of pre- to post-COVID-19 vaccine posts on social media.
    PLoS One. 2025;20:e0337911.
    PubMed         Abstract available

  21. SCHWARTZ AR, Tate JP, Lehmann LS, King JT Jr, et al
    Advance directives prior to COVID-19 diagnosis in a United States national healthcare system.
    PLoS One. 2025;20:e0338825.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  22. DIAMANT ES, Yeh PJ
    Rapid morphological change in an urban bird due to COVID-19 restrictions.
    Proc Natl Acad Sci U S A. 2025;122:e2520996122.
    PubMed         Abstract available

  23. PETROVA B, Syphurs C, Culhane AJ, Chen J, et al
    MTHFR allele and one-carbon metabolic profile predict severity of COVID-19.
    Proc Natl Acad Sci U S A. 2025;122:e2509118122.
    PubMed         Abstract available


    Vaccine

  24. WANG L, Li L, Yang W, Pang X, et al
    Immunogenicity and safety of inactivated quadrivalent influenza vaccines in children aged 6-35 months: A multi-center, randomized, double-blind, active-controlled clinical trial.
    Vaccine. 2025;71:128113.
    PubMed         Abstract available

  25. YU S, Zheng B, Zhao J, Jiang L, et al
    Vaccine fatigue, perceived risk and trust: Unraveling the motivational drivers of influenza vaccination in Chinese adults using the COM-B model.
    Vaccine. 2025;72:128112.
    PubMed         Abstract available

Source: 

____
Labels:

Comments

Post a Comment

Popular posts from this blog

#Neuroinvasive #Oropouche virus in a patient with #HIV from extra-Amazonian #Brazil

By G.M.
{Excerpt} A novel reassortant Oropouche virus (OROV) lineage (with medium [M], large [L], and small [S] RNA segments : M1L2S2) has driven Brazil's largest and most geographically widespread OROV epidemic , expanding beyond the endemic Amazon basin to establish local transmission across multiple Brazilian states and other previously unaffected Latin American countries . The rapid spread of this lineage underscores its evolutionary potential and reinforces its significance as a public health threat .1 Similar to chikungunya and Zika viruses, expanding arboviruses can exhibit unexpected clinical and epidemiological shifts , including vertical transmissions , neuroinvasive effects, and potentially fatal outcomes.2–4 Although OROV typically causes self-limited febrile illness, accumulating clinical and experimental evidence suggests neurotropic potential .5 This Correspondence describes the first confirmed case of neuroinvasive OROV infection caused by the emergent M1L2S2 lineage in ext...
Post a Comment
Read more »

No evidence of immune #exhaustion after repeated #SARS-CoV-2 #vaccination in vulnerable and healthy populations

By G.M.
Abstract Frequent SARS-CoV-2 vaccination in vulnerable populations has raised concerns that this may contribute to T cell exhaustion , which could negatively affect the quality of immune protection. Herein, we examined the impact of repeated SARS-CoV-2 vaccination on T cell phenotypic and functional exhaustion in frail older adults in long-term care (n = 23), individuals on immunosuppressive drugs (n = 10), and healthy adults (n = 43), in Canada . Spike-specific CD4+ and CD8+ T cell levels did not decline in any cohort following repeated SARS-CoV-2 vaccination, nor did the expression of exhaustion markers on spike-specific or total T cells increase. T cell production of multiple cytokines (i.e. polyfunctionality) in response to the spike protein of SARS-CoV-2 did not decline in any cohort following repeated vaccination. None of the cohorts displayed elevated levels of terminally differentiated T cells following multiple SARS-CoV-2 vaccinations. Thus, repeated SARS-CoV-2 vaccination was...
Post a Comment
Read more »

Chimeric #hemagglutinin and #M2 #mRNA #vaccine for broad #influenza subtype protection

By G.M.
Abstract Since multiple and unpredicted influenza viruses cause seasonal epidemics and even high-risk pandemics , developing a universal influenza vaccine is essential to provide broad protection against various influenza subtypes. Combined with the mRNA lipid nanoparticle-encapsulated (mRNA-LNP) vaccine platform and chimeric immunogen strategy , we developed a novel cocktail mRNA vaccine encoding chimeric HAs (cH5/1-BV, cH7/3) and intact M2 (termed Fluaxe), which confers broad protection against major circulating IAVs and IBVs , as well as highly pathogenic avian influenza . Two-dose intramuscular immunization of Fluaxe in mice elicited cross-reactive neutralizing antibodies , T cell responses, and long-lived immunity, resulting in robust protection against multiple lethal influenza virus infections and severe acute lung injuries . In particular, intramuscular administration stimulated systemic immunity together with a prominent lung tropism of memory cells . Moreover, Fluaxe immuniza...
Post a Comment
Read more »